Cancer In Vitro Diagnostics (IVD) Market Future Outlook Showing Expansion Toward $19.85 Billion by 2030
The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Market Value Is Anticipated For The Cancer In Vitro Diagnostics (IVD) Market Over The Period 2026–2030?
The cancer in vitro diagnostics (ivd) market has experienced significant expansion in recent years. This market is set to expand from $14.32 billion in 2025 to $15.32 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 7.0%. The growth observed in prior periods is attributable to factors such as the development of hospital diagnostic infrastructure, an increase in biomarker-based testing, the integration of PCR and immunoassay technologies, the proliferation of cancer screening programs, and advancements in laboratory automation.
The cancer in vitro diagnostics (ivd) market is expected to experience robust growth over the next few years. It is forecast to grow to $19.85 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 6.7%. The expansion during the forecast period can be attributed to factors such as an increasing demand for personalized oncology diagnostics, rising investments in genomic sequencing, the broadening of point-of-care cancer testing, the growing integration of cloud-based diagnostic platforms, and a heightened focus on precision medicine. Key trends anticipated in this period include the increasing adoption of molecular and genomic cancer testing, a rising use of companion diagnostics, the growing integration of AI-driven data analysis, the expansion of liquid biopsy applications, and an enhanced focus on early cancer detection.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=27234&type=smp
What Underlying Factors Are Accelerating The Growth Of The Cancer In Vitro Diagnostics (IVD) Market?
The increasing prevalence of cancer is anticipated to boost the expansion of the cancer in vitro diagnostics (IVD) market in the future. Cancer is characterized by the uncontrolled multiplication and dissemination of abnormal cells within the body, which can infiltrate adjacent tissues and develop into tumors. The heightened incidence of cancer is attributed to an aging demographic, where increased life expectancy and decreased mortality from infectious diseases result in a larger elderly population more susceptible to developing the disease. Cancer in vitro diagnostics (IVD) plays a crucial role in combating cancer by facilitating early and precise detection, ongoing monitoring, and effective management of the condition via laboratory analyses conducted on patient specimens, thereby enabling prompt treatment choices and enhancing patient prognoses. As an illustration, in January 2023, the American Cancer Society, a US-based professional organization dedicated to eliminating cancer, reported that 1,958,310 new cancer cases and 609,820 cancer deaths are projected to occur in 2023 in the United States. Consequently, the rising occurrence of cancer is a key factor propelling the growth of the cancer in vitro diagnostics (IVD) market.
How Is The Cancer In Vitro Diagnostics (IVD) Market Divided Into Its Major Segments?
The cancer in vitro diagnostics (ivd) market covered in this report is segmented –
1) By Product Type: Reagents And Kits, Instruments, Software And Services
2) By Technology: Clinical Chemistry, Immunochemistry Or Immunoassays, Hematology, Coagulation And Hemostasis, Cytogenetics Or Liquid Biopsy Technologies, Molecular Diagnostics, Other Technology
3) By Cancer Type: Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer
4) By End-Users: Hospitals, Laboratories, Academics, Point-Of-Care Testing, Specialty Oncology Diagnostic Centers, Other End Users
Subsegments:
1) By Reagents And Kits: PCR Reagents And Kits, NGS Reagents And Kits, Immunoassay Reagents And Kits, In Situ Hybridization (ISH) Reagents And Kits, Others
2) By Instruments: PCR Instruments, NGS Instruments, Immunoassay Analyzers, ISH Instruments, Others
3) By Software And Services: Data Analysis Software, Laboratory Information Management Systems, Cloud-Based Data Management, Instrument Integration Software, Support And Maintenance Services
How Are Trends Transforming The Cancer In Vitro Diagnostics (IVD) Market Landscape?
Major companies operating in the cancer in vitro diagnostics market are prioritizing innovation in cancer screening, specifically through blood-based colorectal cancer (CRC) screening, to offer convenient, non-invasive, and accurate early detection of colorectal cancer. Blood-based CRC screening entails identifying cancer-associated molecular alterations, such as circulating tumor DNA (ctDNA), within a patient’s blood sample to detect colorectal cancer in average-risk individuals. For instance, in July 2024, Guardant Health, Inc., a U.S.-based precision oncology company, obtained U.S. Food and Drug Administration (FDA) approval for the Guardant Shield blood test as a primary option for colorectal cancer screening. The test functions by analyzing a blood sample for specific ctDNA methylation patterns and other tumor-derived markers; its distinct features include noninvasive collection, high analytical accuracy, and integration with clinical workflows for primary screening; its applications cover colorectal cancer early detection in average-risk adults; benefits encompass improved patient adherence, earlier detection of malignancy, potential reduction in late-stage diagnoses, and eligibility for Medicare reimbursement, thereby broadening population access to screening.
Who Are The Prominent Organizations Shaping The Cancer In Vitro Diagnostics (IVD) Market?
Major companies operating in the cancer in vitro diagnostics (ivd) market are F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Hologic Inc., Illumina Inc., Sysmex Corporation, Exact Sciences Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., Autobio Diagnostics Co Ltd., Transasia Bio-Medicals Ltd., NanoString Technologies Inc., Genetron Holdings Limited, Cancer Diagnostics Inc., J. Mitra & Co. Pvt Ltd., Tulip Diagnostics Pvt Ltd., Guardant Health Inc., Agilent Technologies Inc., BGI Genomics
Read the full cancer in vitro diagnostics (ivd) market report here:
Which Region Is Projected To Dominate The Cancer In Vitro Diagnostics (IVD) Market During The Forecast Period?
North America was the largest region in the cancer in vitro diagnostics (IVD) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cancer in vitro diagnostics (ivd) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Cancer In Vitro Diagnostics (IVD) Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=27234&type=smp
Browse Through More Reports Similar to the Global Cancer In Vitro Diagnostics (IVD) Market 2026, By The Business Research Company
Commercial Fan And Air Purification Equipment Market
Commercial Fan And Air Purification Equipment Market
Farm Equipment Rental Global Market Report
https://www.thebusinessresearchcompany.com/report/farm-equipment-rental-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
